A delivery platform designed to move siRNA medicines precisely into target tissues and continuously generate new pipelines.
The core challenge in siRNA is stable, precise delivery to the right tissue.
RNA medicines are moving beyond rare diseases and liver targets into chronic disease, extra-hepatic tissues and larger patient populations.
7 clinical assets. 20+ preclinical programmes. Listed on HKEX Main Board (6938).